← All Sponsors

SPONSOR

Ascendis Pharma A/S

Total Trials

1

Recruiting

1

Phases

Phase 3

Conditions studied: Turner Syndrome Short Stature Homeobox Gene Mutation Idiopathic Short Stature Small for Gestational Age at Delivery

NCT07221851 Phase 3

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Turner Syndrome